REG - Inspiration Health - Directorate Change

Inspiration HealthcareAnnouncement

28/01/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250128:nRSb8562Ua&default-theme=true

RNS Number : 8562U  Inspiration Healthcare Group PLC  28 January 2025

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

 

Board changes

 

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology
company pioneering best-in-class, specialist neonatal intensive care medical
devices, announces the retirement of Bob Beveridge, Non-Executive Director
("NED") who is stepping down after nine years in line with best practice.
 Bob will be replaced as NED and Chair of the Audit Committee by Richard
Jones. The Board wish to thank Bob for his years of service and commitment to
Inspiration Healthcare during his tenure and are delighted to be able to
appoint Richard to the role. Both changes will come into effect from 31
January 2025.

 

Richard is a seasoned healthcare and life sciences professional with extensive
experience as a board member of publicly listed companies. He has spent more
than 20 years serving in both independent NED and Executive Director roles and
has acted as a key adviser across a diverse range of public and private
companies in the life sciences space. He has expertise across a wide spectrum
of Board issues and has worked extensively outside the UK PLC market having
completed a US reverse merger as CFO for a UK biotech company in 2019.

 

Currently he is a Senior Independent Director and Audit Committee Chair of
Alliance Pharma PLC, an AIM listed international consumer healthcare company
where he is closely involved in all aspects of the business. Formerly, he was
Chief Financial Officer ("CFO") and Company Secretary of the UK and Ireland's
leading supplier of tele-radiology services, Medica Group Ltd. His CFO and
Board experience also includes Mereo Biopharma PLC and Shield Therapeutics
PLC.

 

Roy Davis, Executive Chairman of Inspiration Healthcare said: "We are
delighted to welcome Richard on board, and we are excited to be able to tap
into his extensive capital markets experience, as well as his in-depth
knowledge of the US market where we continue to grow our presence.

 

"On behalf of the Board, I would like to thank Bob for his dedication and
commitment to Inspiration Healthcare over almost a decade. We will be sad to
see him go, and we wish him all the very best for his future plans."

 

Bob Beveridge, outgoing Non-Executive Director said: "I have thoroughly
enjoyed my time with the Inspiration Healthcare team over the years. I believe
they are at a key transitional phase, and I know they will be a great success.
I wish them well for a bright future."

 

Richard Jones, incoming Non-Executive Director added: "I am looking forward to
joining the Board of Inspiration Healthcare and sharing my PLC and life
sciences industry expertise with the team."

 

In accordance with Schedule 2 (g) of the AIM Rules for Companies, Richard
Crispin Morgan Jones (aged 58 years) holds / has held the following
directorships/partnerships in the last five years:

 

 Current directorships / partnerships  Previous directorships / partnerships in last 5 years
 Alliance Pharma plc                   Global Diagnostics Ireland Ltd
 C4X Discovery Holdings Limited        Global Retinopathy Screening Ltd
 Hampshire Topco Limited               JCA Seminars Limited
 Hero Acquisitions Limited             Medica Australia Pty Ltd
 HSS Hire Group plc                    Medica Group Limited
 HSS Hire Service Finance Limited      Medica IT Services Limited
 RCMJ Consultancy Ltd                  Medica Reporting Finance Limited
                                       Medica Reporting Limited
                                       Medica Reporting Services Limited
                                       Medica US Inc
                                       Med-IDX Pty Ltd
                                       Med-IDX UK Limited
                                       Mereo Biopharma 1 Limited
                                       Mereo Biopharma 2 Limited
                                       Mereo Biopharma 3 Limited
                                       Mereo Biopharma 4 Limited
                                       Mereo Biopharma Group plc
                                       Mereo BioPharma Ireland Limited
                                       Mereo MereoCo Inc
                                       Mereo US Holdings Inc
                                       Moonlight Bidco Limited
                                       Moonlight Midco 1 Limited
                                       Moonlight Midco 2 Limited
                                       Moonlight Topco Limited

 

Richard Crispin Morgan Jones does not hold any ordinary shares in the capital
of the Company.  There are no further disclosures to be made in accordance
with AIM Rule 17 or Schedule 2(g) of the AIM Rules for Companies.

 

For further information, please contact:

 

 Inspiration Healthcare Group plc                                                  Tel: +44 (0)330
                                                   175 0000
 Roy Davis, Executive Chair

 Alan Olby, Chief Financial Officer

 Panmure Liberum (Nominated Adviser & Broker)                                      Tel: +44 (0)20
                                                   3100 2000
 Richard Lindley

 Will King

 Walbrook PR Ltd (Media and Investor Relations)    Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com
 Anna Dunphy                                       Mob: +44 (0) 7876 741 001
 Louis Ashe-Jepson                                 Mob: +44 (0) 7747 515 393

 

About Inspiration Healthcare

 

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering
medical technology. Based in the UK, the Company specialises in neonatal
intensive care medical devices, which are addressing a critical need to help
to save the lives and improve the outcomes of patients, starting with the very
first breaths of life.

 

The Company has a broad portfolio of its own products and complementary
distributed products, for use in neonatal intensive care designed to support
even the most premature babies throughout their hospital stay. Its own branded
products range from highly sophisticated capital equipment such as ventilators
for life support through to single-use disposables.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOABRGDBLUDDGUR